Literature DB >> 15915491

Liver transplant recipient selection: MELD vs. clinical judgment.

Michael A Fink1, Peter W Angus, Paul J Gow, S Roger Berry, Bao-Zhong Wang, Vijayaragavan Muralidharan, Christopher Christophi, Robert M Jones.   

Abstract

Minimization of death while waiting for liver transplantation involves accurate prioritization according to clinical status and appropriate allocation of donor livers. Clinical judgment in the Liver Transplant Unit Victoria (LTUV) was compared with Model for End-Stage Liver Disease (MELD) in a retrospective analysis of the LTUV database over the 2-year period August 1, 2002, through July 31, 2004. A total of 1,118 prioritization decisions occurred. Decisions were concordant in 758 (68%), comparing priorities assigned by clinical judgment with those assigned by MELD, P < 0.01. A total of 263 allocation decisions occurred. Decisions were concordant in 190 (72%) and 203 (77%) of the cases, comparing donor liver allocation with prioritization by MELD and clinical judgment, respectively. Of the 52 patients allocated a liver, only 23 would have been allocated on the basis of MELD while 29 had been prioritized on the waiting list in the week prior to transplantation. A total of 10 patients died on the waiting list in the 2-year period (annual adult waiting list mortality is 9.3%). Patients who subsequently died waiting were 3 times as likely to be prioritized by MELD as clinical judgment (29% vs. 9%, respectively). One half (3 of 6) of the patients who could have received a donor liver but who died waiting would have been allocated the organ on the basis of MELD. In conclusion, an allocation process based on MELD rather than clinical judgment would significantly alter organ allocation in Australia and may reduce waiting list mortality.

Entities:  

Mesh:

Year:  2005        PMID: 15915491     DOI: 10.1002/lt.20428

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  9 in total

1.  Survival tree and MELD to predict long term survival in liver transplantation waiting list.

Authors:  Emília Matos do Nascimento; Basilio de Bragança Pereira; Samanta Teixeira Basto; Joaquim Ribeiro Filho
Journal:  J Med Syst       Date:  2010-03-03       Impact factor: 4.460

2.  The impact of MELD allocation on simultaneous liver-kidney transplantation.

Authors:  Julie A Thompson; John R Lake
Journal:  Curr Gastroenterol Rep       Date:  2009-02

3.  Nutritional status and liver transplantation.

Authors:  Manuela Merli; Michela Giusto; Valerio Giannelli; Cristina Lucidi; Oliviero Riggio
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

Review 4.  Model for end-stage liver disease: end of the first decade.

Authors:  Sumeet K Asrani; W Ray Kim
Journal:  Clin Liver Dis       Date:  2011-10-01       Impact factor: 6.126

5.  The effect of changes of model for end-stage liver disease score during waiting time on post-liver transplant mortality.

Authors:  Mohammad A B Al-Freah; Edward J Gane; Vicki Livingstone; John McCall; Stephen Munn
Journal:  Hepatol Int       Date:  2011-06-30       Impact factor: 6.047

6.  A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.

Authors:  Michael D Leise; W Ray Kim; Walter K Kremers; Joseph J Larson; Joanne T Benson; Terry M Therneau
Journal:  Gastroenterology       Date:  2011-02-18       Impact factor: 22.682

Review 7.  Model for end-stage liver disease score and MELD exceptions: 15 years later.

Authors:  Sumeet K Asrani; Patrick S Kamath
Journal:  Hepatol Int       Date:  2015-05-28       Impact factor: 6.047

Review 8.  Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant.

Authors:  Gorden Muduma; Rhodri Saunders; Isaac Odeyemi; Richard F Pollock
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

9.  Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis Improve Cirrhosis Outcome Prediction: A Modified Seven-Stage Model as a Clinical Alternative to MELD.

Authors:  Chien-Hao Huang; Hsiao-Jung Tseng; Piero Amodio; Yu-Ling Chen; Sheng-Fu Wang; Shang-Hung Chang; Sen-Yung Hsieh; Chun-Yen Lin
Journal:  J Pers Med       Date:  2020-10-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.